☆ 4.6 Article

The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer

ASIAN JOURNAL OF SURGERY (2023)

Related references

Note: Only part of the references are listed.

Article Urology & Nephrology

Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate

Jinge Zhao et al.

Summary: The study found genetic alterations differences between patients with and without intraductal carcinoma of the prostate (IDC-P), with higher proportions of DNA repair pathway and AR pathway alterations in IDC-P carriers. For IDC-P carriers, TP53 mutation was associated with shorter castration-resistant-free survival, and BRCA2 alteration was related to rapid PSA progression in patients receiving abiraterone treatment.

BJU INTERNATIONAL (2022)

Add to Collection

Review Oncology

Clinical and Biological Features of Neuroendocrine Prostate Cancer

Yasutaka Yamada et al.

Summary: NEPC can develop de novo but more commonly arises as a result of lineage plasticity, where prostate cancer cells adopt alternative lineage programs to bypass therapy. Genomic analyses from patient biopsies combined with preclinical modeling have further driven tumor proliferation and expression of downstream neuronal and neuroendocrine lineage pathways.

CURRENT ONCOLOGY REPORTS (2021)

Add to Collection

Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Add to Collection

Article Oncology

De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome

Eman Abdulfatah et al.

Summary: The neuroendocrine transdifferentiation of high-grade prostate cancer (PCA-NT) is characterized by high-grade nuclei, high mitotic activity, reduced PSA expression, high Ki67, and functional inactivation of the RB1 pathway. Most cases present at an advanced stage with adverse radiological findings, metastasis at the time of diagnosis, and high mortality rates. Pathologists should maintain a sensitive threshold for performing immunostains, particularly Ki67 and CyclinD1, in their day-to-day clinical practice due to the prognostic and therapeutic implications of PCA-NT.

MEDICAL ONCOLOGY (2021)

Add to Collection

Review Urology & Nephrology

Optimizing the diagnosis and management of ductal prostate cancer

Weranja Ranasinghe et al.

Summary: Ductal adenocarcinoma of the prostate is the most common variant histological subtype of prostate cancer, with an aggressive clinical course. Diagnosis and treatment pose challenges, and evidence for treatment is predominantly based on retrospective data.

NATURE REVIEWS UROLOGY (2021)

Add to Collection

Article Oncology

Mucinous Prostate Cancer Shows Similar Prognosis to Typical Prostate Acinar Carcinoma: A Large Population-Based and Propensity Score-Matched Study

Feng Zhao et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Andrology

Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer

Sha Zhu et al.

ASIAN JOURNAL OF ANDROLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?

Tao Wu et al.

PROSTATE (2019)

Add to Collection

Article Cell Biology

Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases

Hemamali Samaratunga et al.

HISTOPATHOLOGY (2017)

Add to Collection

Article

Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study

Yu-Peng Wu et al.

Oncotarget (2017)

Add to Collection

Article Medicine, General & Internal

Clinicopathological Features of Prostate Ductal Carcinoma: Matching Analysis and Comparison with Prostate Acinar Carcinoma

Aram Kim et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2015)

Add to Collection

Article Endocrinology & Metabolism

Is There any Prognostic Impact of Intraductal Carcinoma of Prostate in Initial Diagnosed Aggressively Metastatic Prostate Cancer?

Tao Zhao et al.

PROSTATE (2015)

Add to Collection

Article Pathology

Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer

S. S. Jeetle et al.

VIRCHOWS ARCHIV (2012)

Add to Collection

Article Oncology

PROGNOSTIC SIGNIFICANCE OF NEUROENDOCRINE DIFFERENTIATION IN PATIENTS WITH GLEASON SCORE 8-10 PROSTATE CANCER TREATED WITH PRIMARY RADIOTHERAPY

Daniel J. Krauss et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Add to Collection

Article Oncology

An Aggressive Signet Ring Cell Carcinoma of the Prostate in a Japanese Man

Yasuhiro Hashimoto et al.

CASE REPORTS IN ONCOLOGY (2011)

Add to Collection

Review Medicine, General & Internal

Primary Signet Ring Cell Carcinoma of the Prostate

Jonathan N. Warner et al.

MAYO CLINIC PROCEEDINGS (2010)

Add to Collection

Article Pathology

Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy - A study of 47 cases

Adeboye O. Osunkoya et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)

Add to Collection

Article Urology & Nephrology

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability

Sven Gunia et al.

WORLD JOURNAL OF UROLOGY (2008)

Add to Collection

Article Oncology

Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate

Thomas N. Eade et al.

CANCER (2007)

Add to Collection

Article Urology & Nephrology

Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy

Matthias May et al.

SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2007)

Add to Collection

Article Urology & Nephrology

Mucinous adenocarcinoma of the prostate does not confer poor prognosis

Brian R. Lane et al.

UROLOGY (2006)

Add to Collection

Article Urology & Nephrology

Neuroendocrine differentiation is not prognostic of failure after radical prostatectomy but correlates with tumor volume

G Ahlgren et al.

UROLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.